Home
(current)
answers
trials near you
news
events
Below are links to research studies in heart and blood vessels. If you are thinking of taking part in one, please talk to your doctor.
Abatacept (CTLA4-Ig) for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (Wegener's)
BHF PROTECT-TAVI
BRITISH:Using CMR scar as risk indication tool in NICM and severe LVSD
Cardiovascular magnetic resonance imaging in healthy volunteers
EASY-AS - A Randomised Controlled Trial of Early surgery in severe ASYmptomatic Aortic Stenosis
EMBRACE Study - Randomised Controlled study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy
EVIDENCE - Evaluating Diuretics in Normal Care: a cluster randomised evaluation of hypertension prescribing policy.
Fast Field Cyclic-Magnetic Resonance Imaging (FFC-MRI): A New Diagnostic that Reveals Acutely Inflamed Coronary Artery Plaques by Detecting Fat Dysfunction
HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation.
Impact of early valve replacement on myocardial scar in asymptomatic Aortic Stenosis: an observational MRI study of randomised cohorts
Is There a Genetic Predisposition for Acute Stress-Induced (Takotsubo)Cardiomyopathy?
Mineralys 301 - A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Lorundrostat in Subjects with Uncontrolled and Resista
Periodontal health in patients with acute myocardial infarction
POC-ET - Point of Care Evaluation of high-sensitivity cardiac Troponin
STARR STUDY - Establishing the incidence of Tako-tsubo cardiomyopathy in Scotland.
TEMPEST - A randomised, double-blind, placebo-controlled, phase 2 evaluation of the efficacy and mechanism of trientine in patients with hypertrophic cardiomyopathy.
The HEart iN Renal dIsease (HENRI) study V1.0 - Treatment decision-making in myocardial infarction for people with advanced kidney disease: A qualitative study.